Bio-Reference Laboratories, Inc. (NASDAQ:BRLI)

CAPS Rating: 4 out of 5

An independent clinical laboratory servicing the New York metropolitan area that offers a comprehensive list of laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation, monitoring and treatment of diseases.

Recs

0
Player Avatar someicg (41.88) Submitted: 1/10/2012 9:05:45 PM : Outperform Start Price: $17.09 BRLI Score: +15.51

consensus screen

Featured Broker Partners


Advertisement